Diabetes as a risk factor for greater COVID-19 severity and in- hospital death: A meta-analysis of observational studies
Fecha
2020Autor
Mantovani, Alessandro
Byrne, Christopher D.
Zheng, Ming-Hua
Documentos PDF
Imagenes y Videos
Resumen
Aims: To estimate the prevalence of established diabetes and its association with the
clinical severity and in-hospital mortality associated with COVID-19.
Data synthesis: We systematically searched PubMed, Scopus and Web of Science, from 1st
January 2020 to 15th May 2020, for observational studies of patients admitted to hospital with
COVID-19. Meta-analysis was performed using random-effects modeling. A total of 83 eligible
studies with 78,874 hospitalized patients with laboratory-confirmed COVID-19 were included.
The pooled prevalence of established diabetes was 14.34% (95% CI 12.62e16.06%). However,
the prevalence of diabetes was higher in non-Asian vs. Asian countries (23.34% [95% CI 16.40
e30.28] vs. 11.06% [95% CI 9.73e12.39]), and in patients aged 60 years vs. those aged <60 years
(23.30% [95% CI 19.65e26.94] vs. 8.79% [95% CI 7.56e10.02]). Pre-existing diabetes was associated with an approximate twofold higher risk of having severe/critical COVID-19 illness
(n Z 22 studies; random-effects odds ratio 2.10, 95% CI 1.71e2.57; I
2 Z 41.5%) and ~threefold
increased risk of in-hospital mortality (n Z 15 studies; random-effects odds ratio 2.68, 95% CI
2.09e3.44; I
2 Z 46.7%). Funnel plots and Egger’s tests did not reveal any significant publication
bias.
Palabras clave
Diabetes; COVID-19; Coronavirus disease; 2019; SARS-CoV-2; Meta-analysisEnlace al recurso
https://doi.org/10.1016/j.numecd.2020.05.014Colecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.